Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

221.43
BATS BZX Real-Time Price
As of 2:53pm ET
 +1.91 / +0.87%
Today’s Change
184.50
Today|||52-Week Range
261.27
+5.44%
Year-to-Date
Has Allergan's Pullback Run Its Course?
1:29pm / TheStreet.com - Paid Partner Content
JPMorgan Still Gives Allergan Love
May 19 / TheStreet.com - Paid Partner Content
NWQ Managers Sells Pfizer, Viacom, Edison
May 22 / GuruFocus News - Paid Partner Content
AbbVie Down on Humira Patent Loss: Is More Damage in Store?
May 18 / Zacks.com - Paid Partner Content
John Paulson Sells VMware, Hewlett Packard, Several Other Holdings
May 19 / GuruFocus News - Paid Partner Content
Allergan's Irritable Bowel Drug Viberzi Approved in Canada
May 17 / Zacks.com - Paid Partner Content
John Paulson Sells VMware, Hewlett Packard, Several Others
May 19 / GuruFocus News - Paid Partner Content
Loading Up on More Allergan
May 17 / TheStreet.com - Paid Partner Content
Amgen (AMGN) Submits BLA to FDA for Migraine Drug Erenumab
May 19 / Zacks.com - Paid Partner Content
Cardiome (CRME) Q1 Loss Wider Than Expected, Sales Miss
May 17 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close219.52
Today’s open219.76
Day’s range219.36 - 221.65
Volume70,881
Average volume (3 months)2,966,820
Market cap$73.6B
Dividend yield1.26%
Data as of 2:53pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+19.13%
Earnings growth (next 5 years)+13.70%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.03

Competitors

 Today’s
change
Today’s
% change
ABTAbbott Laboratories+0.10+0.23%
NVONovo Nordisk-0.03-0.07%
AZNAstraZeneca+0.14+0.43%
LLYEli Lilly and Co+1.09+1.42%
Data as of 2:53pm ET, 05/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$3.97
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts